Published in Heart Rhythm on July 20, 2007
Telemedicine Enabling Patients in Self-care Behaviors | NCT04297735
Atrial-selective effects of chronic amiodarone in the management of atrial fibrillation. Heart Rhythm (2008) 1.96
Potent antiarrhythmic effects of chronic amiodarone in canine pulmonary vein sleeve preparations. J Cardiovasc Electrophysiol (2009) 1.78
Amiodarone pulmonary toxicity. Can Respir J (2009) 1.67
Synergistic electrophysiologic and antiarrhythmic effects of the combination of ranolazine and chronic amiodarone in canine atria. Circ Arrhythm Electrophysiol (2009) 1.13
Atrial-selective sodium channel block for the treatment of atrial fibrillation. Expert Opin Emerg Drugs (2009) 1.12
Hyperacute drug-induced hepatitis with intravenous amiodarone: case report and review of the literature. Drug Healthc Patient Saf (2013) 0.85
Falling between the cracks: a case of amiodarone toxicity. CMAJ (2011) 0.83
Drug Induced Steatohepatitis: An Uncommon Culprit of a Common Disease. Biomed Res Int (2015) 0.80
Geriatrician interventions on medication prescribing for frail older people in residential aged care facilities. Clin Interv Aging (2015) 0.79
Amiodarone-Induced Pulmonary Toxicity - A Frequently Missed Complication. Clin Med Insights Case Rep (2016) 0.78
Amiodarone monitoring practices in pediatric hospitals in the United States. Pediatr Cardiol (2013) 0.77
Effects of the novel amiodarone-like compound SAR114646A on cardiac ion channels and ventricular arrhythmias in rats. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.77
Pulmonary toxicity in a renal transplant recipient treated with amiodarone and everolimus: a case of hypothetical synergy and a proposal for a screening protocol. Case Rep Nephrol Urol (2014) 0.75
The diagnostic utility of chest computed tomography scoring for the assessment of amiodarone-induced pulmonary toxicity. Korean J Intern Med (2014) 0.75
Pulmonary Vein Sleeves as a Pharmacologic Model for the Study of Atrial Fibrillation. Electrofisiol Arritm (2010) 0.75
Atrial fibrillation. J Biomed Res (2013) 0.75
Severe muscle cramps after intravenous administration of amiodarone--a novel, potentially dose-dependent adverse effect. Br J Clin Pharmacol (2011) 0.75
Ranolazine versus amiodarone for prevention of postoperative atrial fibrillation. Future Cardiol (2011) 0.75
Early Amiodarone-Induced Pulmonary Toxicity after Endovascular Aneurysm Repair: A Case Report. Int J Angiol (2014) 0.75
Hepatic Dysfunction in Patients Receiving Intravenous Amiodarone. South Med J (2016) 0.75
Adverse effects of long-term amiodarone therapy. Korean J Intern Med (2014) 0.75
A practical approach to the management of patients with atrial fibrillation. Heart Asia (2010) 0.75
High-risk medication use by nursing home residents before and after hospitalization. Med Care (2014) 0.75
Sotalol versus Amiodarone in Treatment of Atrial Fibrillation. J Atr Fibrillation (2016) 0.75
Atrial tachyarrhythmia in adult congenital heart disease. World J Cardiol (2017) 0.75
Effects of a novel amiodarone-like compound SAR114646A on the pig atrium and susceptibility to ventricular fibrillation in dogs and pigs. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.75
Rapid onset of amiodarone induced pulmonary toxicity after lung lobe resection - A case report and review of recent literature. Ann Med Surg (Lond) (2017) 0.75
Amiodarone-Induced Third Degree Atrioventricular Block and Extreme QT Prolongation Generating Torsade Des Pointes in Paroxysmal Atrial Fibrillation. J Atr Fibrillation (2016) 0.75
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med (2011) 22.39
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med (2014) 10.62
Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med (2012) 8.84
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med (2013) 6.82
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline. Am J Respir Crit Care Med (2015) 6.03
Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials. Am J Respir Crit Care Med (2012) 5.33
Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score. Chest (2013) 4.71
A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. N Engl J Med (2010) 4.19
Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation (2010) 4.07
Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation (2004) 4.04
Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med (2005) 4.03
The physiological role of mitochondrial calcium revealed by mice lacking the mitochondrial calcium uniporter. Nat Cell Biol (2013) 3.39
Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2010) 3.37
Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA (2007) 3.32
Three techniques for integrating data in mixed methods studies. BMJ (2010) 3.19
Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet (2013) 3.17
Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation (2010) 3.17
Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway. Circ Res (2004) 2.98
Using dabigatran in patients with stroke: a practical guide for clinicians. Stroke (2011) 2.97
Preconditioning results in S-nitrosylation of proteins involved in regulation of mitochondrial energetics and calcium transport. Circ Res (2007) 2.97
Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes. Circ Res (2004) 2.91
Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration. Circ Res (2007) 2.91
Hypercontractile female hearts exhibit increased S-nitrosylation of the L-type Ca2+ channel alpha1 subunit and reduced ischemia/reperfusion injury. Circ Res (2006) 2.84
ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary. Heart Rhythm (2008) 2.75
Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med (2007) 2.69
Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial. JAMA (2010) 2.68
Subglottic secretion drainage for preventing ventilator-associated pneumonia: a meta-analysis. Am J Med (2005) 2.67
Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation (2004) 2.63
Prevalence and prognosis of unclassifiable interstitial lung disease. Eur Respir J (2012) 2.57
A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med (2012) 2.54
Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3-kinase--dependent pathway is cardioprotective. Circ Res (2002) 2.50
Classification and natural history of the idiopathic interstitial pneumonias. Proc Am Thorac Soc (2006) 2.40
Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function. Circ Res (2006) 2.33
Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2011) 2.32
Targeted deletion of thioredoxin-interacting protein regulates cardiac dysfunction in response to pressure overload. Circ Res (2007) 2.31
2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 2.23
Nonvalvular cardiovascular device-related infections. Circulation (2003) 2.19
Relative utility of magnetic resonance imaging and right ventricular angiography to diagnose arrhythmogenic right ventricular cardiomyopathy. J Interv Card Electrophysiol (2004) 2.16
ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Cardiovasc Electrophysiol (2002) 2.14
Cyclophilin D controls mitochondrial pore-dependent Ca(2+) exchange, metabolic flexibility, and propensity for heart failure in mice. J Clin Invest (2010) 2.12
The nuclear receptor ERRalpha is required for the bioenergetic and functional adaptation to cardiac pressure overload. Cell Metab (2007) 2.11
The Food and Drug Administration decision not to approve the 110 mg dose of dabigatran: give us a way out. Am J Med (2012) 2.08
Electrocardiographic and electrophysiological characteristics in idiopathic ventricular arrhythmias originating from the papillary muscles in the left ventricle: relevance for catheter ablation. Circ Arrhythm Electrophysiol (2010) 2.06
Heart rate predicts outcomes in an implantable cardioverter-defibrillator population. Circulation (2009) 2.06
Long-term structural failure of coaxial polyurethane implantable cardioverter defibrillator leads. Pacing Clin Electrophysiol (2002) 2.04
Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials. J Am Coll Cardiol (2004) 2.03
Vitamin D deficiency in multicultural primary care: a case series of 299 patients. Br J Gen Pract (2007) 2.02
Viral infection in acute exacerbation of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2011) 2.00
Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Circulation (2004) 1.99
Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial. Eur Heart J (2013) 1.99
Nuclear miRNA regulates the mitochondrial genome in the heart. Circ Res (2012) 1.95
Why, and how, mixed methods research is undertaken in health services research in England: a mixed methods study. BMC Health Serv Res (2007) 1.91
Inhibition of delta-protein kinase C protects against reperfusion injury of the ischemic heart in vivo. Circulation (2003) 1.80
Control of rate versus rhythm in rheumatic atrial fibrillation: a randomized study. Indian Heart J (2004) 1.79
The quality of mixed methods studies in health services research. J Health Serv Res Policy (2008) 1.75
Multicenter experience with failed and recalled implantable cardioverter-defibrillator pulse generators. Heart Rhythm (2006) 1.74
Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia. Circulation (2004) 1.73
Influence of left ventricular lead location on outcomes in the COMPANION study. J Cardiovasc Electrophysiol (2009) 1.72
Mitochondrial dysfunction and apoptosis underlie the pathogenic process in alpha-B-crystallin desmin-related cardiomyopathy. Circulation (2005) 1.72
Clinical problem-solving. Why "why" matters. N Engl J Med (2004) 1.72
ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. Heart Rhythm (2008) 1.72
Alternative endpoints for mortality in studies of patients with atrial fibrillation: the AFFIRM study experience. Heart Rhythm (2004) 1.70
Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury. Circ Res (2004) 1.69
Qualitative study investigating the process of giving anti-smoking advice in general practice. Patient Educ Couns (2004) 1.67
New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop. Circulation (2011) 1.66
Nosocomial pneumonia: state of the science. Am J Infect Control (2006) 1.65
Pulmonary rehabilitation in interstitial lung disease: benefits and predictors of response. Chest (2008) 1.64
Protein S-nitrosylation and cardioprotection. Circ Res (2010) 1.63
Essential role of nitric oxide in acute ischemic preconditioning: S-nitros(yl)ation versus sGC/cGMP/PKG signaling? Free Radic Biol Med (2012) 1.61
Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation. Circ Res (2008) 1.60
Resumption of electrical conduction in previously isolated pulmonary veins: rationale for a different strategy? Circulation (2004) 1.59
Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats. Am J Physiol Heart Circ Physiol (2009) 1.59
Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. J Cardiovasc Electrophysiol (2003) 1.59
Predictors of mortality in rheumatoid arthritis-related interstitial lung disease. Respirology (2013) 1.57
Noninvasive programmed ventricular stimulation early after ventricular tachycardia ablation to predict risk of late recurrence. J Am Coll Cardiol (2012) 1.57
Ethnic differences in self-harm, rates, characteristics and service provision: three-city cohort study. Br J Psychiatry (2010) 1.57
Estrogen receptor-beta activation results in S-nitrosylation of proteins involved in cardioprotection. Circulation (2009) 1.56
Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern. Chest (2009) 1.56
Ventricular tachycardia originating from the posterior papillary muscle in the left ventricle: a distinct clinical syndrome. Circ Arrhythm Electrophysiol (2008) 1.54
Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report. Am J Respir Crit Care Med (2014) 1.54
Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure. Eur Respir J (2013) 1.54
Cyclophilin D modulates mitochondrial acetylome. Circ Res (2013) 1.53
Safety of sports participation in patients with implantable cardioverter defibrillators: a survey of heart rhythm society members. J Cardiovasc Electrophysiol (2006) 1.53
Risk prediction in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2012) 1.52
Circadian patterns in the occurrence of malignant ventricular tachyarrhythmias triggering defibrillator interventions in patients with hypertrophic cardiomyopathy. Heart Rhythm (2009) 1.51